Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 44 for “"Zero order release"”.

  1. Design, development, and evaluation of a scalable micro perforated drug delivery device capable of long-term zero order release

    … of drug for prolonged periods. A controlled release for extended duration would replace the need for multiple and frequent dosing. Local drug release would provide added benefit as a lower dose of drug at the target site will be needed as opposed to higher doses required by whole body …

    texas Repository record for Design, development, and evaluation of a scalable micro perforated drug delivery device capable of long-term zero order release (opens in a new tab)

  2. Formulation and Fabrication of a Novel Subcutaneous Implant for the Zero-Order Release of Selected Protein and Small Molecule Drugs

    … When using subcutaneous implant, drug release needs to be strictly controlled. There are three major groups of controlled release methods. Solvent controlled system is already used as osmotic implant. Matrix controlled system is used in Zoladex® implant to treat cancer. Membrane …

    temple Repository record for Formulation and Fabrication of a Novel Subcutaneous Implant for the Zero-Order Release of Selected Protein and Small Molecule Drugs (opens in a new tab)

  3. A controlled release technique using microporous membranes

    A novel controlled release device based on aqueous-organic partitioning is described. The device comprises a reservoir, bounded by a microporous or porous membrane in the form of a hollow fiber or flat film. The reservoir liquid phase and the pore liquid phase are immiscible. The agent partitions …

    njit Repository record for A controlled release technique using microporous membranes (opens in a new tab)

  4. PERSONALISED DRUG DELIVERY AND TESTING BY 3D PRINTING

    … (Fused Deposition Modelling), a customisable, zero-order release kinetic oral tablet scaffold was developed. However, peptide drugs that hold huge potential, may not be suitable for oral administration. Subsequently, a high-resolution 3D printer (Digital Light Processing) was employed to …

    nus Repository record for PERSONALISED DRUG DELIVERY AND TESTING BY 3D PRINTING (opens in a new tab) Download file for PERSONALISED DRUG DELIVERY AND TESTING BY 3D PRINTING (opens in a new tab)

  5. SILOXANE-CONTAINING PHOSPHOLIPIDS AS POTENTIAL DRUG DELIVERY SYSTEMS

    … of drugs, stability of liposomes and drug release profile. Optimizing any of these characteristics will hence improve the efficiency of liposomes as DDS. This study reveals the potential for siloxane-containing phospholipids to display a higher entrapment capacity than conventional …

    brock Repository record for SILOXANE-CONTAINING PHOSPHOLIPIDS AS POTENTIAL DRUG DELIVERY SYSTEMS (opens in a new tab)

  6. Topical Nanoparticulate Formulation of Drugs for Ocular Keratitis

    … that all NP formulations are non-toxic. In vitro release of prodrugs from NP showed a biphasic release pattern with an initial burst phase followed by a sustained phase. Such burst effect was completely eliminated when NP were suspended in thermosensitive gels with near zero-order release …

    umkc Repository record for Topical Nanoparticulate Formulation of Drugs for Ocular Keratitis (opens in a new tab)

  7. Fabrication and Characterization of Composite Membranes as Drug-Delivering Duraplasty for Stroke Treatment

    … swelling ratio implying that their initial drug release would be lower than the other samples. They were the strongest membranes and they still maintained some elasticity. The DWMS had a higher drug encapsulation efficiency than the SWMS and the DWMS composite membrane drug release profile showed …

    ottawa-retro Repository record for Fabrication and Characterization of Composite Membranes as Drug-Delivering Duraplasty for Stroke Treatment (opens in a new tab)

  8. BIOMIMETIC STRATEGIES TO CONTROL THERAPEUTIC RELEASE FROM NOVEL DNA NANOPARTICLES

    … exploited these properties for the controlled release of therapeutic drugs. In this dissertation, a biomimetic approach to controlling drug release is exhibited by specifically manipulating the architecture of novel, DNA nanoparticles to take advantage of drug binding mechanisms of action. …

    rowan Repository record for BIOMIMETIC STRATEGIES TO CONTROL THERAPEUTIC RELEASE FROM NOVEL DNA NANOPARTICLES (opens in a new tab)

  9. Carriers for Controlled Release of Allyl Isothiocyanate, Diacetyl and Cinnamaldehyde for Antimicrobial Active Packaging

    … were developed and characterized for controlled release of allyl isothiocyanate (AITC), diacetyl, and cinnamaldehyde. Controlled releases of AITC and diacetyl were achieved by incorporating these volatile compounds into polymer blends of different molecular weights. Results showed that increasing …

    guelph Repository record for Carriers for Controlled Release of Allyl Isothiocyanate, Diacetyl and Cinnamaldehyde for Antimicrobial Active Packaging (opens in a new tab)

  10. Articular cartilage- and synoviocyte-binding small molecule drug delivery system for the intra-articular treatment of osteoarthritis

    … (rhodamine B) exhibited a sustained, near-zero order release over 16 days. Additionally, PEG microgels functionalized with synoviocyte- or cartilage-targeting peptides, presented specific binding to rabbit and human synoviocytes, and to bovine articular cartilage in vitro, respectively. …

    gatech Repository record for Articular cartilage- and synoviocyte-binding small molecule drug delivery system for the intra-articular treatment of osteoarthritis (opens in a new tab)

  11. Effect of ethyl oleate and oleic anhydride on metronidazole release from poly(ortho esters) films

    … oleic acid, were compared with regard to the release characteristics of metronidazole (1 0% w/w) from poly( ortho esters) films in distilled water at 3 7 °C. The rate of release of metronidazole from poly(miho esters) films was dependent on the ethyl oleate or oleic anhydride concentrations. …

    u-pacific Repository record for Effect of ethyl oleate and oleic anhydride on metronidazole release from poly(ortho esters) films (opens in a new tab)

  12. Delayed Release of Hydrophilic Solutes from Capsules

    … when the gels are placed in water. Solute release can be completely stopped if the gel is covered by a thin shell of paraffin wax (melting point Tm ~ 57°C); in such ‘capsules’, the wax shell is a hydrophobic solid. Here, we vary the design of our capsules to achieve ‘delayed release’ of …

    maryland Repository record for Delayed Release of Hydrophilic Solutes from Capsules (opens in a new tab)

  13. Recombinantly Engineered Polypeptides for Drug Delivery

    … regimens. While most methods achieve first-order release at best, zero-order release is the ultimate goal of controlled release systems, wherein the drug is released at a constant rate that is independent of concentration. Towards this end, we have developed a system that achieves near …

    duke Repository record for Recombinantly Engineered Polypeptides for Drug Delivery (opens in a new tab)

  14. Growth factor presentation from PEGylated fibrin gels to enhance vasculogenesis

    I developed a system to release multiple growth factors from PEGylated fibrin gels with varying profiles to induce vasculogenesis from embedded human MSCs. Zero-order release can be obtained by conjugating a growth factor with a homobifunctional, amine-reactive, PEG derivative. Growth factors can …

    texas Repository record for Growth factor presentation from PEGylated fibrin gels to enhance vasculogenesis (opens in a new tab)

  15. Evaluation of calcium alginate beads as a prolonged release delivery system for an orally active iron chelator

    … calcium alginate beads to facilitate prolonged release was investigated. Beads were produced by dripping a sodium alginate solution containing 15 mg/mL DMHP into a curing solution of 4% CaCl$\sb2$, and curing. Beads were then tray dried for 24 h. Dissolution tests were done using the basket …

    manitoba Repository record for Evaluation of calcium alginate beads as a prolonged release delivery system for an orally active iron chelator (opens in a new tab)

  16. Controlled release of isoniazid by hybrid systems

    … pore volume, surface charge, and INH adsorption/release. The clay exhibiting an ideal pore volume (~0.100 cm³/g) displayed superior retention and sustained release in neural environment. Optimal adsorption (~115 mg/g) was achieved with montmorillonite at pH 2, where INH is positively charged and …

    ets-quebec Download PDF for Controlled release of isoniazid by hybrid systems (opens in a new tab)

  17. Subdermal implants for controlled release of small molecule drugs

    … capable of providing long-term controlled release of two small molecule drugs at targeted therapeutic doses: dapivirine (DPV), a non-nucleoside reverse transcriptase inhibitor (NNRTI) for HIV-1 pre-exposure prophylaxis (PrEP); and cholecalciferol (vitamin D3), to alleviate widespread …

    qu-belfast Repository record for Subdermal implants for controlled release of small molecule drugs (opens in a new tab) Download PDF for Subdermal implants for controlled release of small molecule drugs (opens in a new tab)

  18. THICKNESS-VARYING AND MAGNESIUM-COATED VANCOMYCIN-LOADED POLYCAPROLACTONE RESERVOIR-TYPE IMPLANTS FOR CONTROLLED DRUG RELEASE

    … thickness and magnesium coating on vancomycin release for reservoir-type implants. In vitro drug release profiles were measured for 30 days and evaluated using a zero-order release model alongside a membrane-diffusion model based on Fick’s laws. Thickness-varying implants and implants …

    jhu Repository record for THICKNESS-VARYING AND MAGNESIUM-COATED VANCOMYCIN-LOADED POLYCAPROLACTONE RESERVOIR-TYPE IMPLANTS FOR CONTROLLED DRUG RELEASE (opens in a new tab) Embargoed until 2029-08-01

  19. Development of hot melt extruded solid dispersion formulation for stabilising co-amorphous compounds

    … co-amorphous system which also led to hindered release of paracetamol. The dissolution rates of felodipine from the co-amorphous systems showed no significant improvement in comparison to crystalline felodipine indicating the rapid recrystallization of felodipine during the dissolution process. …

    east-anglia Download PDF for Development of hot melt extruded solid dispersion formulation for stabilising co-amorphous compounds (opens in a new tab)

  20. Ανάπτυξη στερεών φαρμακομορφών με τρισδιάστατη εκτύπωση για εξατομικευμένη θεραπεία

    … formulations, that: i) present controlled release depending on their geometrical features, ii) incorporate multiple active pharmaceutical ingredients, exhibiting different release profiles, iii) incorporate other pharmaceutical formulations, which they release at specific pH values and iv) …

    greece Repository record for Ανάπτυξη στερεών φαρμακομορφών με τρισδιάστατη εκτύπωση για εξατομικευμένη θεραπεία (opens in a new tab)

Page 1 of 3